| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.042 | 5.071 | 5.360 | 5.174 | 5.269 | 6.559 | 7.109 | 8.391 | 8.582 | 10.241 |
| Total Income - EUR | 5.056 | 5.090 | 5.360 | 5.180 | 5.269 | 6.559 | 7.109 | 8.391 | 8.582 | 10.241 |
| Total Expenses - EUR | 4.802 | 4.649 | 5.187 | 5.280 | 5.081 | 4.551 | 4.277 | 4.149 | 4.702 | 6.539 |
| Gross Profit/Loss - EUR | 254 | 442 | 173 | -100 | 188 | 2.008 | 2.831 | 4.242 | 3.880 | 3.703 |
| Net Profit/Loss - EUR | 103 | 340 | 119 | -151 | 135 | 1.942 | 2.760 | 4.158 | 3.794 | 3.059 |
| Employees | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Freudmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 307 | 694 | 769 | 638 | 764 | 2.738 | 5.431 | 9.577 | 13.296 | 9.124 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 2.363 | 2.310 | 2.845 | 12.778 | 0 |
| Cash | 307 | 694 | 769 | 0 | 764 | 376 | 3.120 | 6.732 | 518 | 9.124 |
| Shareholders Funds | 22 | 362 | 475 | 315 | 444 | 2.378 | 5.085 | 9.258 | 13.024 | 7.830 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 285 | 332 | 295 | 323 | 320 | 361 | 346 | 319 | 272 | 1.294 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Freudmed S.r.l.